STAR Growth Index

Baili Tianheng's Innovative Drug SI-B036 Approved for Clinical Trials in Late-Stage Solid Tumors by NMPA

Belayidiantianheng Receives Approval for Clinical Trials of Iza-bren Combination Therapy

SmartSens released FY2026 Q1 earnings on April 30 After-Market (BJT), actual revenue CNY 2.112 B, actual EPS CNY 0.59

Cambricon released FY2026 Q1 earnings on April 29 During-Market (BJT), actual revenue CNY 2.885 B (forecast CNY 1.793 B), actual EPS CNY 1.5973 (forecast CNY 0.7919)

BR-Tech released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 92.29 M, actual EPS CNY 0.03

JSCQ released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 247.7 M, actual EPS CNY 0

Genrix Bio released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 67.25 M, actual EPS CNY -0.41

Freewon released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 540.31 M, actual EPS CNY 0.12

BNCT released FY2026 Q1 earnings on April 29 Pre-Market (BJT), actual revenue CNY 9.401 M, actual EPS CNY -0.17

OPM released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 182.16 M, actual EPS CNY 0.07

Aidea Pharma released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 178.02 M, actual EPS CNY 0.02

BLT released FY2026 Q1 earnings on April 29 Pre-Market (BJT), actual revenue CNY 325.91 M, actual EPS CNY 0.0611

GCORE released FY2026 Q1 earnings on April 29 Pre-Market (BJT), actual revenue CNY 1.881 B, actual EPS CNY 0

Ninebot released FY2026 Q1 earnings on April 29 After-Market BJT, actual revenue CNY 5.87 B (forecast CNY 5.978 B), actual EPS CNY 0.266 (forecast CNY 0.2249)

Chengdu Jouav released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 52.09 M, actual EPS CNY -0.21

SYE released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 2.411 B (forecast CNY 2.718 B), actual EPS CNY 0.52

SINOMED released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 139.74 M, actual EPS CNY 0.06

JEE released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 1 B, actual EPS CNY 0.15

YOEC released FY2026 Q1 earnings on April 28 Pre-Market (BJT), actual revenue CNY 84.8 M, actual EPS CNY 0.05

JJE released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 326.35 M, actual EPS CNY -0.15

科创200

000690

588080

科创综指

000698

000688

588210

588270

<p>On April 9th, the series of STAR Market indices collectively adjusted, with the STAR Growth Index falling by 0.2%, the STAR 100 Index down by 0.5%, the STAR 50 Index decreasing by 0.7%, the STAR Composite Index dropping by 0.8%, and the STAR 200 Index experiencing a decline of 0.9%. Despite short-term fluctuations, the earnings expectations for the STAR 50 constituent stocks have improved, with projected operating revenue expected to grow by 21.53% year-on-year in 2026, and net profit attributable to the parent company significantly increasing to 98.68%. The relevant ETFs under E Fund have performed excellently, with the industry distribution and key indicators of the STAR 50 ETF, STAR 100 ETF, and STAR 200 ETF demonstrating their investment value</p>

腾讯新闻 - 财经

E Fund China Science and Technology Innovation Board 50 Component ETF

STAR 100

STAR 50

E Fund SSE Science and Technology Innovation Board 100 ETF

E Fund SSE Science and Technology Innovation Board 200 ETF

The STAR Market index collectively adjusted, and profit expectations have warmed up

588880

399626

<p>The STAR Market series indices have adjusted, with the STAR 100 Index down 1.2%, the STAR 200 Index down 1.3%, the STAR Composite Index down 1.4%, the STAR 50 Index down 1.7%, and the STAR Growth Index down 2.7%. Huajin Securities recommends focusing on the dual main lines of technology growth and cyclical sectors in the short term, with a strategy of buying on dips, and paying attention to the policies and industrial trends in sectors such as electronics, new energy, telecommunications, non-ferrous metals, chemicals, military industry, machinery and equipment, media, computers, and pharmaceuticals</p>

Huatai-PB SSE Science and Technology Innovation Board 100 ETF

SME-ChiNext 500 Growth

The STAR Market series indices have adjusted, presenting layout opportunities for the technology main line. Pay attention to the subsequent performance of the STAR 50 ETF E Fund (588080)

STAR Growth Index(000690.SH)

The STAR Market index collectively adjusted, and profit expectations have warmed up

The STAR Market series indices have adjusted, presenting layout opportunities for the technology main line. Pay attention to the subsequent performance of the STAR 50 ETF E Fund (588080)